These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3047198)

  • 1. Prediction of successful suppression of sustained ventricular tachyarrhythmias by serial drug testing from data derived at the initial electrophysiologic study.
    Kuchar DL; Rottman J; Berger E; Freeman CS; Garan H; Ruskin JN
    J Am Coll Cardiol; 1988 Oct; 12(4):982-8. PubMed ID: 3047198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease.
    Meissner MD; Kay HR; Horowitz LN; Spielman SR; Greenspan AM; Kutalek SP
    Am J Cardiol; 1988 May; 61(13):1050-5. PubMed ID: 3284319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy.
    Rae AP; Sokoloff NM; Webb CR; Spielman SR; Greenspan AM; Horowitz LN
    J Am Coll Cardiol; 1985 Aug; 6(2):410-6. PubMed ID: 4019928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
    Waxman HL; Buxton AE; Sadowski LM; Josephson ME
    Circulation; 1983 Jan; 67(1):30-7. PubMed ID: 6847803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
    Greenspan AM; Spielman SR; Webb CR; Sokoloff NM; Rae AP; Horowitz LN
    Am J Cardiol; 1985 Aug; 56(4):277-84. PubMed ID: 4025166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
    Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
    Rae AP; Spielman SR; Kutalek SP; Kay HR; Horowitz LN
    Am J Cardiol; 1987 Feb; 59(4):291-5. PubMed ID: 3544793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical predictors of arrhythmia inducibility in survivors of cardiac arrest: importance of gender and prior myocardial infarction.
    Freedman RA; Swerdlow CD; Soderholm-Difatte V; Mason JW
    J Am Coll Cardiol; 1988 Oct; 12(4):973-8. PubMed ID: 3417994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative electrophysiologic effects of intravenous and oral procainamide in patients with sustained ventricular arrhythmias.
    Marchlinski FE; Buxton AE; Vassallo JA; Waxman HL; Cassidy DM; Doherty JU; Josephson ME
    J Am Coll Cardiol; 1984 Dec; 4(6):1247-54. PubMed ID: 6209319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of serial electropharmacological testing in managing patients resuscitated from cardiac arrest.
    Raviele A; Di Pede F; Delise P; Piccolo E
    Pacing Clin Electrophysiol; 1984 Sep; 7(5):850-60. PubMed ID: 6207498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic and clinical factors influencing response to class IA antiarrhythmic agents in patients with inducible sustained monomorphic ventricular tachycardia.
    Gold RL; Haffajee CI; Alpert JS
    Am Heart J; 1986 Jul; 112(1):9-13. PubMed ID: 3728294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple monomorphic ventricular tachycardia configurations predict failure of antiarrhythmic drug therapy guided by electrophysiologic study.
    Mitrani RD; Biblo LA; Carlson MD; Gatzoylis KA; Henthorn RW; Waldo AL
    J Am Coll Cardiol; 1993 Oct; 22(4):1117-22. PubMed ID: 8409050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electropharmacologic effect of a standard dose of intravenous procainamide in patients with sustained ventricular tachycardia.
    Rials SJ; Britchkow D; Marinchak RA; Kowey PR
    Clin Cardiol; 2000 Mar; 23(3):171-4. PubMed ID: 10761804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paired comparisons of efficacy of intravenous and oral procainamide in patients with inducible sustained ventricular tachyarrhythmias.
    Interian A; Zaman L; Velez-Robinson E; Kozlovskis P; Castellanos A; Myerburg RJ
    J Am Coll Cardiol; 1991 Jun; 17(7):1581-6. PubMed ID: 2033190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with coronary artery disease as assessed by electrophysiologic studies.
    Rae AP; Greenspan AM; Spielman SR; Sokoloff NM; Webb CR; Kay HR; Horowitz LN
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1494-9. PubMed ID: 3890509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of the outcome of electrophysiologic study in patients with ventricular tachyarrhythmias.
    Schoenfeld MH; McGovern B; Garan H; Kelly E; Grant G; Ruskin JN
    J Am Coll Cardiol; 1985 Aug; 6(2):298-306. PubMed ID: 4019918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: evaluation by programmed stimulation and ambulatory electrocardiogram.
    Steinbeck G; Bach P; Haberl R
    J Am Coll Cardiol; 1986 Oct; 8(4):949-58. PubMed ID: 3760368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy.
    Milner PG; Dimarco JP; Lerman BB
    Pacing Clin Electrophysiol; 1988 May; 11(5):562-8. PubMed ID: 2456534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proarrhythmic effects of antiarrhythmic drugs during programmed ventricular stimulation in patients without ventricular tachycardia.
    Au PK; Bhandari AK; Bream R; Schreck D; Siddiqi R; Rahimtoola SH
    J Am Coll Cardiol; 1987 Feb; 9(2):389-97. PubMed ID: 2433319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous Procainamide for Predicting the Response of Sustained Ventricular Tachycardia to Type III Antiarrhythmic Drugs.
    Snow JS; Cohen MB; Jadonath RL; Cohen TJ
    J Invasive Cardiol; 1997 Jan; 9(1):40-44. PubMed ID: 10762873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.